MedTrace Logo

Pharmacotherapy and Psychotherapy in the Treatment of Erectile Dysfunction

NCT04126252 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2019-12-02

No results posted yet for this study

Summary

The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with four arms involving a control group.

Conditions

Interventions

DRUG

Sildenafil Citrate 50Mg Tab

The Group A received sildenafil citrate 50 mg on demand for a period of max 3 months.

BEHAVIORAL

Cognitive Behavioral Psychotherapy

The Group B received cognitive behavior psychotherapy for a period of max 3 months.

COMBINATION_PRODUCT

Combined or Integrated Therapy

The Group C received the combined therapeutic approach for a period of max 3 months.

OTHER

Placebo

The Group D received no treatment or placebo for a period of max 3 months.

Sponsors & Collaborators

  • International Islamic University, Islamabad

    lead OTHER

Principal Investigators

  • Ahmad Bilal · International Islamic University, Islamabad, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-29
Primary Completion
2019-09-03
Completion
2019-09-03

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126252 on ClinicalTrials.gov